Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report
JCO Precision Oncology · 2024
DOI: 10.1200/po.24.00007 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von Chia-I Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Afatinib, Bevacizumab, Carcinoma, Non-Small-Cell Lung, ErbB Receptors. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
- Medical Affairs, Guardant Health AMEA, Singapore.
- Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
ORCID-Profile: Chiao-En Wu
Zitieren
APA
Shen, C. I., Chang, J. C., Jain, S., Olsen, S., & Wu, C. E. (2024). Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report. JCO Precision Oncology. https://doi.org/10.1200/po.24.00007
Vancouver
Shen CI, Chang JC, Jain S, Olsen S, Wu CE. Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report. JCO Precision Oncology. 2024. doi:10.1200/po.24.00007
BibTeX
@article{Shen2024,
author = {Shen, Chia-I and Chang, Ju-Chen and Jain, Suyog and Olsen, Steve and Wu, Chiao-En},
title = {Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C–Mutant Non–Small Cell Lung Cancer: A Case Report},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.24.00007}
}
EUVIMED